Insights

Why a2 Milk, BrainChip, Oil Search, & Starpharma shares are dropping lower

A2 Milk Company Ltd (ASX:A2M) and Starpharma Holdings Limited (ASX:SPL) shares are two of four dropping lower on Wednesday…
The post Why a2 Milk, BrainChip, Oil Search, & Starpharma shares are dropping lower appeared first on Motley Fool Australia. –

The S&P/ASX 200 Index (ASX: XJO) has come under pressure on Wednesday and is on course to record a sizeable decline. The benchmark index is down 1.15% to 5,883.1 points in late morning trade.

Four shares that have fallen more than most today are listed below. Here’s why they are dropping lower:

The A2 Milk Company Ltd (ASX: A2M) share price has dropped lower again and is down 2% to $14.28. Investors have been selling the infant formula and fresh milk company’s shares since its disappointing update earlier this week. One broker that wasn’t impressed is Citi. It has retained its sell rating and cut its price target to $14.20 amid concerns that daigou weakness could persist for longer.

The BrainChip Holdings Ltd (ASX: BRN) share price is down 8% to 34 cents. This latest decline means the artificial intelligence technology company’s shares are now down 65% over the last three weeks. Investors appear to now recognise that BrainChip’s shares were vastly overvalued after an incredible share price gain in 2020. At one stage BrainChip’s market capitalisation was well over $1 billion.

The Oil Search Limited (ASX: OSH) share price has fallen 3% to $2.71. Investors have been selling this energy producer’s shares after oil prices sank lower overnight. The catalyst for the pullback in oil prices was concerns over rising coronavirus cases and the impact this could have on demand.  

The Starpharma Holdings Limited (ASX: SPL) share price has fallen 6.5% to $1.50. This morning the dendrimer products developer’s shares returned from a trading halt after successfully completing a $45 million institutional placement. These funds were raised at $1.50 per new share and will be used primarily to support the development of a COVID-19 nasal spray. The remainder will be used to support the development of multiple, high-value DEP clinical assets, and DEP pipeline expansion.

These 3 stocks could be the next big movers in 2020

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

Find out the names of our 3 Post COVID Stocks – For FREE!

*Returns as of 6/8/2020

More reading

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Starpharma Holdings Limited. The Motley Fool Australia owns shares of A2 Milk. The Motley Fool Australia has recommended Starpharma Holdings Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Why a2 Milk, BrainChip, Oil Search, & Starpharma shares are dropping lower appeared first on Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!